Tracon Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tracon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • Tracon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.91M, a 274% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$7.31M, a 64% increase year-over-year.
  • Tracon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$9.27M, a 66.8% increase from 2022.
  • Tracon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$27.9M, a 1.6% increase from 2021.
  • Tracon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$28.3M, a 74.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$7.31M -$2.91M -$2.13M -274% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$5.17M -$3.21M +$4.1M +56.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$9.27M $407K +$6.24M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$15.5M -$1.59M +$4.79M +75.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$20.3M -$779K +$5.46M +87.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$25.8M -$7.31M +$2.13M +22.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$27.9M -$5.83M +$1.83M +23.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$29.7M -$6.38M +$504K +7.33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$30.2M -$6.24M +$2.61M +29.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$32.8M -$9.45M -$4.49M -90.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$28.3M -$7.66M -$3.49M -83.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$24.9M -$6.88M -$3.03M -78.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$21.8M -$8.85M -$4.53M -105% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$17.3M -$4.96M -$1.07M -27.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$16.2M -$4.18M -$365K -9.58% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-08
Q3 2020 -$15.9M -$3.85M +$1.23M +24.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$17.1M -$4.31M +$1.93M +30.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$19M -$3.88M +$3.28M +45.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$22.3M -$3.81M +$3.92M +50.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 -$26.2M -$5.08M +$4M +44.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$30.2M -$6.24M +$3.5M +35.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$33.7M -$7.16M +$1.03M +12.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$34.7M -$7.73M -$1.38M -21.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$33.4M -$9.08M -$10.5M -752% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$22.9M -$9.74M -$3.41M -53.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$19.5M -$8.19M -$1.27M -18.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$18.2M -$6.35M -$279K -4.59% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$17.9M $1.39M +$6.99M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$24.9M -$6.33M +$1.68M +21% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$26.6M -$6.92M -$626K -9.95% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$26M -$6.08M +$4.76M +43.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$30.7M -$5.6M +$638K +10.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$31.4M -$8.01M -$5.33M -198% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$26M -$6.29M -$2.58M -69.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$23.5M -$10.8M -$8.58M -381% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$14.9M -$6.24M -$4.53M -266% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$10.4M -$2.68M -$1.79M -201% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$8.56M -$3.71M -$2.38M -179% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$6.18M -$2.25M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$1.7M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$891K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$1.33M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.